Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-31 Purchase | 2026-09-08 7:01 pm | ALTERITY THERAPEUTICS LTD | ATHE | Marks Peter Ashley Director | 47,620 | $0.5 | $23,810 | 191,340 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-15 Option Award | 2026-06-23 7:57 pm | 2026-06-15 2031-06-15 | ALTERITY THERAPEUTICS LTD | ATHE | Babarczy Julian Michael Director | 2,000,000 | $0 | 2,000,000 (Indirect) | View |
| 2026-06-15 Option Award | 2026-06-23 7:38 pm | 2026-06-15 2031-06-15 | ALTERITY THERAPEUTICS LTD | ATHE | Gozlan Lawrence Bernard Director | 1,000,000 | $0 | 1,000,000 (Indirect) | View |
Ownership | 2026-04-15 7:49 pm | N/A N/A | ALTERITY THERAPEUTICS LTD | ATHE | Stamler David Allen Chief Executive Officer | 0 | $0 | 346,123,874 (Direct) | View |
Ownership | 2026-04-10 08:21 am | N/A N/A | ALTERITY THERAPEUTICS LTD | ATHE | Gozlan Lawrence Bernard Director | 0 | $0 | 56,060,607 (Indirect) | View |
Ownership | 2026-04-10 07:57 am | N/A N/A | ALTERITY THERAPEUTICS LTD | ATHE | Marks Peter Ashley Director | 0 | $0 | 32,424,243 (Indirect) | View |
Ownership | 2026-04-09 9:58 pm | N/A N/A | ALTERITY THERAPEUTICS LTD | ATHE | Macnish Niven Abby Sarah Chief Financial Officer | 0 | $0 | 606,055 (Indirect) | View |